AQST

Aquestive Therapeutics, Inc.

Phase 2 AI-extracted

Anaphylm

Type 1 allergic reactions, including anaphylaxis

Resolved

7days ago

Phase 2 readout · ~ Jun 30, 2026 estimated

What's at stake Phase 2 trial results for Anaphylm in Type 1 allergic reactions, including anaphylaxis are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 16h ago

“Reaffirms guidance to resubmit the Anaphylm NDA in Q3 2026”

Add to calendar Post on X Reddit

Provenance